Literature DB >> 12354499

Leishmania spp infection in injecting drug users.

Juan A Pineda, J Martín-Sánchez, J Macías, F Morillas.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12354499     DOI： 10.1016/S0140-6736(02)11056-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

Review 2.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 3.  Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.

Authors:  Ana Nieto; Gustavo Domínguez-Bernal; José A Orden; Ricardo De La Fuente; Nadia Madrid-Elena; Javier Carrión
Journal:  Vet Res       Date:  2011-02-23       Impact factor: 3.683

4.  Risk Factors of Leishmania Infection among HIV-Infected Patients in Trang Province, Southern Thailand: A Study on Three Prevalent Species.

Authors:  Sakarn Charoensakulchai; Lertwut Bualert; Jipada Manomat; Mathirut Mungthin; Saovanee Leelayoova; Peerapan Tan-Ariya; Suradej Siripattanapipong; Tawee Naaglor; Phunlerd Piyaraj
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

5.  Visceral leishmaniasis caused by Leishmania infantum in a Spanish patient in Argentina: What is the origin of the infection? Case report.

Authors:  Joaquina Martín-Sánchez; José M Navarro-Mari; Juan Pasquau-Liaño; Oscar D Salomón; Francisco Morillas-Márquez
Journal:  BMC Infect Dis       Date:  2004-06-29       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.